Mettler-Toledo International (NYSE:MTD) had its price objective cut by research analysts at Robert W. Baird from $675.00 to $630.00 in a research note issued to investors on Friday. The firm currently has a “neutral” rating on the medical instruments supplier’s stock. Robert W. Baird’s price objective would indicate a potential upside of 3.14% from the company’s previous close.
A number of other research analysts also recently commented on the company. Morgan Stanley increased their price objective on Mettler-Toledo International from $550.00 to $580.00 and gave the company an “equal weight” rating in a report on Friday. Citigroup upgraded Mettler-Toledo International from a “neutral” rating to a “buy” rating and increased their price objective for the company from $685.00 to $692.00 in a report on Friday. Barclays began coverage on Mettler-Toledo International in a report on Thursday, January 4th. They issued an “equal weight” rating and a $625.00 price objective on the stock. Evercore ISI began coverage on Mettler-Toledo International in a report on Wednesday, January 3rd. They issued an “in-line” rating and a $625.00 price objective on the stock. Finally, Zacks Investment Research downgraded Mettler-Toledo International from a “buy” rating to a “hold” rating in a report on Tuesday, November 7th. Six research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $651.44.
Mettler-Toledo International (NYSE:MTD) traded up $10.45 on Friday, hitting $610.82. The stock had a trading volume of 78,969 shares, compared to its average volume of 173,459. Mettler-Toledo International has a fifty-two week low of $460.00 and a fifty-two week high of $697.26. The stock has a market cap of $15,680.00, a P/E ratio of 43.04, a P/E/G ratio of 2.38 and a beta of 1.08. The company has a current ratio of 1.46, a quick ratio of 1.09 and a debt-to-equity ratio of 1.75.
In other news, insider Thomas Caratsch sold 1,333 shares of the firm’s stock in a transaction that occurred on Monday, November 27th. The stock was sold at an average price of $634.44, for a total value of $845,708.52. Following the completion of the sale, the insider now directly owns 1,270 shares of the company’s stock, valued at approximately $805,738.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Simon Kirk sold 4,726 shares of the firm’s stock in a transaction that occurred on Thursday, November 30th. The shares were sold at an average price of $629.01, for a total value of $2,972,701.26. The disclosure for this sale can be found here. Insiders have sold a total of 36,359 shares of company stock worth $22,940,960 in the last 90 days. 5.20% of the stock is currently owned by company insiders.
Several institutional investors and hedge funds have recently bought and sold shares of MTD. Dimensional Fund Advisors LP lifted its holdings in shares of Mettler-Toledo International by 6.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 96,295 shares of the medical instruments supplier’s stock valued at $56,671,000 after buying an additional 5,659 shares during the period. Macquarie Group Ltd. lifted its holdings in shares of Mettler-Toledo International by 8.1% in the 2nd quarter. Macquarie Group Ltd. now owns 10,146 shares of the medical instruments supplier’s stock valued at $5,971,000 after buying an additional 764 shares during the period. Cornerstone Capital Management Holdings LLC. lifted its holdings in shares of Mettler-Toledo International by 17.7% in the 2nd quarter. Cornerstone Capital Management Holdings LLC. now owns 5,279 shares of the medical instruments supplier’s stock valued at $3,106,000 after buying an additional 793 shares during the period. Cubist Systematic Strategies LLC increased its stake in Mettler-Toledo International by 151.8% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 1,229 shares of the medical instruments supplier’s stock valued at $723,000 after purchasing an additional 741 shares in the last quarter. Finally, Nomura Holdings Inc. increased its stake in Mettler-Toledo International by 375.4% in the 2nd quarter. Nomura Holdings Inc. now owns 2,510 shares of the medical instruments supplier’s stock valued at $1,477,000 after purchasing an additional 1,982 shares in the last quarter. 91.79% of the stock is owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: “Robert W. Baird Lowers Mettler-Toledo International (MTD) Price Target to $630.00” was first posted by American Banking News and is the property of of American Banking News. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://www.americanbankingnews.com/2018/02/10/mettler-toledo-international-mtd-stock-rating-reaffirmed-by-robert-w-baird.html.
About Mettler-Toledo International
Mettler-Toledo International Inc is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications.
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.